Manufacturing News of Note—Taro recalls seizure drugs; explosions at API plant  

A closeup of a stock market ticker
(Pixabay)

> Taro Pharmaceuticals is voluntarily recalling two lots of phenytoin oral suspension USP, 125 mg/5 mL both in 237 mL bottles, to the consumer level because they may not re-suspend when shaken, potentially leading to dosing issues. Release 

> The Massachusetts State Fire Marshal determined that several explosions Feb. 13 at a PCI Synthesis API plant in Newburyport occurred during a sampling procedure. No one was injured. Release  

> Catalent Pharma Solutions will offer nearly $500 million in senior unsecured notes due 2028. Release 

> Italy-based CDMO and API maker Dipharma has completed a new quality control laboratory and kilolab at its CDMO site in Kalamazoo, Michigan. Release